ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1831

Study Of Serum Levels Of Osteocalcin (s-OC) On Patients With Diffuse Idiopathic Skeletal Hyperostosis (DISH) and Ankylosing Spondilitis (AS)

Mariela Geneva-Popova1, Stojan Andreev2, Pavel Pavlov3, Daniel Ilev1 and Stanislava Popova1, 1Clinic of Rheumatology, Medical University, Plovdiv, Plovdiv, Bulgaria, 2Department of Rheumatology, MHAT Tokuda, Sofia, Bulgaria, 3University Lab, Medical University, Plovdiv, Plovdiv, Bulgaria

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Diffuse idiopathic skeletal hyperostosis (DISH), gout and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Biology and Pathology of Bone and Joint (Bone and Arthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Osteocalcin (bone Gla protein), one of the basic markers for bone matabolism, has not been thoroughly studied on patients with DISH and AS. It is a specific product of the osteoblasts, in bones it connects with hydroxyapatite and in the presence of calcium it plays the role of a promoter of the accumulation of calcium in the bone matrix. That’s how osteocalcin takes part in the regulation of  bone ossification.

The aim of the study is to estimate the serum levels of osteocalcin on patients with DISH and AS.

Methods: s-OC is estimated on 55 patients with DISH, 25 patients with AS, 50 patients with spondylosis and 15 particularly healthy people aged 55-65, 10 particularly healthy people aged 20-25. The measuring of the s-OC is done by ELISA „sandwitch“  method, with a kit of eBioscience, Austria. The statistic processing is done with SPSS 19 programme  (p<0.001) .

Results:

The average measurements of s-OC of patients with DISH and AS are higher in comparison with the results of patients with spondylosis and healthy people, regardless of their age (p<0.05). (table 1)

Table 1: Results of average measurements of s-OC of patients with DISH, spondylosis, AS, young and old controlled  in ng/ml

Disease

Number of patients

Referent measurments

Min

Max

DISH

55

6,37±0,619

0,80

23.90

Spondylitis

50

1,19±0,024

0,70

1.90

AS

23

7,27±1,80

0,40

41.50

Young people

10

1,22±0,236

0,50

3.20

Old control group

15

1,78±0,226

1,20

3.60

Conclusion: s-OC is significantly increased on patients with DISH and AS in comparison with the results of patients with spondylosis and healthy people, but it is really hard to explain the reason why at the present moment. Hypothetically, this might be a result as a sequence of events, based on which is damage of the spinal cord (stimulation of inflammatory proteins, on-going osteoporosis, compresion fractures, hyperinsulinemia which is a result from metabolic disorders, etc.), the endurance of the vertebrae is decreased and the body increases the production of osteocalcin from the osteoblasts to form compensatory more bone substance. That‘s how the organism adapts to the new changes.

Measuring the levels of serum osteocalcin can be used for early diagnose of DISH due to a difference between the serum levels on patients with DISH and spondylosis, with which differential diagnose is mostly done.


Disclosure:

M. Geneva-Popova,
None;

S. Andreev,
None;

P. Pavlov,
None;

D. Ilev,
None;

S. Popova,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/study-of-serum-levels-of-osteocalcin-s-oc-on-patients-with-diffuse-idiopathic-skeletal-hyperostosis-dish-and-ankylosing-spondilitis-as/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology